Ifosfamide-induced Fanconi Syndrome

Overview

Journal Lancet

Publisher Elsevier

Specialty General Medicine

Date 1989 Jun 10

PMID 2566853

Citations 10

Authors

R A Newbury-Ecob

V W Noble

P R Barbor

Affiliations

Soon will be listed here.

Citing Articles

Ifosfamide-induced nephrogenic diabetes insipidus and Fanconi syndrome in a patient with femur osteosarcoma.

Concepcion-Zavaleta M, Ramos-Torres G, Quiroz-Aldave J, Durand-Vasquez M, Ildefonso-Najarro S, de Jesus Alvarado-Leon E Caspian J Intern Med. 2024; 15(4):743-747.

PMID: 39359431 PMC: 11444112. DOI: 10.22088/cjim.15.4.743.

Recurrent Fanconi Syndrome Induced by Lenalidomide: A Case Report.

Sharra I, Lhoir M, Des Grottes J, Vaes M, Guerisse F Cureus. 2024; 16(8):e66118.

PMID: 39108773 PMC: 11300179. DOI: 10.7759/cureus.66118.

Anticancer drug-induced kidney disorders.

Kintzel P Drug Saf. 2001; 24(1):19-38.

PMID: 11219485 DOI: 10.2165/00002018-200124010-00003.

Hypophosphatemic rickets after ifosfamide treatment.

Newbury-Ecob R, Barbor P BMJ. 1989; 299(6693):258.

PMID: 2504390 PMC: 1836945. DOI: 10.1136/bmj.299.6693.258-a.

Nephrotoxicity after ifosfamide.

Skinner R, Pearson A, Price L, Coulthard M, Craft A Arch Dis Child. 1990; 65(7):732-8.

PMID: 2386379 PMC: 1792439. DOI: 10.1136/adc.65.7.732.